Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Protagonist Therapeutics Inc (PTGX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 406,323
  • Shares Outstanding, K 20,480
  • Annual Sales, $ 0 K
  • Annual Income, $ -37,180 K
  • 36-Month Beta -1.66
  • Price/Sales 46.28
  • Price/Cash Flow N/A
  • Price/Book 7.01

Price Performance

See More
Period Period Low Period High Performance
1-Month
19.00 +2.00%
on 12/20/17
21.68 -10.61%
on 01/02/18
+0.39 (+2.05%)
since 12/15/17
3-Month
14.10 +37.45%
on 11/02/17
21.68 -10.61%
on 01/02/18
+3.44 (+21.58%)
since 10/16/17
52-Week
8.00 +142.25%
on 05/25/17
21.68 -10.61%
on 01/02/18
-0.16 (-0.82%)
since 01/13/17

Most Recent Stories

More News
Penumbra (PEN) Forms JV on Virtual Reality in Health Space

Penumbra's (PEN) joint venture with Sixense Enterprises indicates formation of a leading digital health platform in the field of virtual reality technology.

PTGX : 19.38 (-2.32%)
AKTX : 3.70 (-6.33%)
WBA : 76.03 (-0.05%)
PEN : 87.20 (-4.33%)
Protagonist Therapeutics Granted Two New US Patents for Peptide Drug Candidates PTG-100 and PTG-300

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) today announced that two new U.S. patents have been issued that further strengthen the intellectual property protection for the company's novel peptide drug...

PTGX : 19.38 (-2.32%)
New Products Aid Boston Scientific, LOTUS Relaunch Lag Ails

Boston Scientific (BSX) grows on product launches and international expansion. LOTUS relaunch delay hurts sales.

PTGX : 19.38 (-2.32%)
AKTX : 3.70 (-6.33%)
XOMA : 31.56 (-6.38%)
BSX : 26.98 (-1.75%)
Thermo Fisher Buys Phenom-World, Aids Analytical Instruments

On completion of Phenom-World purchase, Thermo Fisher (TMO) plans to integrate the business into its Analytical Instruments segment.

PTGX : 19.38 (-2.32%)
AKTX : 3.70 (-6.33%)
XOMA : 31.56 (-6.38%)
TMO : 208.01 (-1.03%)
PetMed Rides on Solid Reorders & New Orders Amid Competition

PetMed (PETS) strives to implement several strategies to revitalize the top line, focusing on advertising efficiency to boost new order sales and shifting sales to higher margin items.

PTGX : 19.38 (-2.32%)
AKTX : 3.70 (-6.33%)
PETS : 51.78 (-2.19%)
XOMA : 31.56 (-6.38%)
Dicerna Pharmaceuticals (DRNA) in Focus: Stock Moves 6.2% Higher

Dicerna Pharmaceuticals (DRNA) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

PTGX : 19.38 (-2.32%)
DRNA : 8.65 (+2.73%)
Pieris Pharmaceuticals (PIRS) Soars: Stock Adds 15.2% in Session

Pieris Pharmaceuticals (PIRS) saw a big move last session, as its shares jumped more than 15% on the day, amid huge volumes.

PTGX : 19.38 (-2.32%)
PIRS : 6.92 (-7.24%)
PDL BioPharma, Inc. (PDLI) Jumps: Stock Rises 8.2%

PDL BioPharma, Inc, (PDLI) was a big mover last session, as the company saw its shares more than 8% on the day amid huge volumes.

PTGX : 19.38 (-2.32%)
PDLI : 2.79 (-1.76%)
PDL BioPharma, Inc. (PDLI) Jumps: Stock Rises 8.2%

PDL BioPharma, Inc. (PDLI) was a big mover last session, as the company saw its shares more than 8% on the day amid huge volumes.

PTGX : 19.38 (-2.32%)
PDLI : 2.79 (-1.76%)
Zacks.com highlights: Net 1 UEPS Technologies, Protagonist Therapeutics, Tilly's, Nuance Communications and Dorian LPG

Zacks.com highlights: Net 1 UEPS Technologies, Protagonist Therapeutics, Tilly's, Nuance Communications and Dorian LPG

NUAN : 17.09 (unch)
PTGX : 19.38 (-2.32%)
LPG : 7.69 (-1.16%)
UEPS : 12.26 (+0.33%)
TLYS : 14.12 (-2.08%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The Company's initial lead product candidates consists of PTG-100 and...

See More

Key Turning Points

2nd Resistance Point 20.87
1st Resistance Point 20.13
Last Price 19.38
1st Support Level 18.83
2nd Support Level 18.27

See More

52-Week High 21.68
Last Price 19.38
Fibonacci 61.8% 16.45
Fibonacci 50% 14.84
Fibonacci 38.2% 13.23
52-Week Low 8.00

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.